Connection

DOUGLAS J HARRISON to Phosphatidylinositol 3-Kinases

This is a "connection" page, showing publications DOUGLAS J HARRISON has written about Phosphatidylinositol 3-Kinases.
  1. Evaluation of the pan-class I phosphoinositide 3-kinase (PI3K) inhibitor copanlisib in the Pediatric Preclinical Testing Consortium in vivo models of osteosarcoma. Pediatr Blood Cancer. 2023 01; 70(1):e30017.
    View in: PubMed
    Score: 0.531
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.